Global Female Fertility and Pregnancy Rapid Test Market are Expected to Foresee Significant Growth. North America to lead the growth!

The global female fertility and pregnancy rapid test market is expected to register a CAGR of around 5% over the period of 2021-2027. This is mainly due to the stringent government regulations coupled with the growing focus of major stakeholders in the healthcare industry to adopt to make female fertility and pregnancy rapid test products more sustainable and eco-friendlier. Major healthcare companies are investing heavily in their products due to rising infertility cases, an increase in the demand for at-home diagnostic devices, awareness of healthcare expenditure, and the rising incidence of gynecological disorders. For instance, as reported by American Pregnancy Association (APA), infertility affects approximately 1 out of every 6 couples, and female infertility accounts for about one-third of all infertility cases. Furthermore, various factors such as hormonal imbalance can cause conditions like irregular and heavy bleeding, indescribable miscarriages, and abnormalities of the uterus which is responsible for excessive use of female fertility and pregnancy rapid tests and significantly contributes to the market for aesthetic devices. Therefore, the market for female fertility and pregnancy rapid tests is expected to witness significant growth during the forecast period.

For a detailed analysis of the Global Female fertility and pregnancy rapid test Market browse through – https://univdatos.com/report/female-fertility-and-pregnancy-rapid-test-market/

Based on test type, the market is classified into FSH urine test, LH urine test, hCG blood test, and hCG urine test. Amongst types, the LH urine test category accounted for a significant share of the market. This is mainly due to this test detecting a rise in luteinizing hormone (LH) in the urine. A rise in this hormone signals the ovary to release the egg which helps determine the time in the menstrual cycle when getting pregnant is most likely.

Based on distribution channels, the market is categorized into retail stores, online stores, gynecology and fertility clinics, and others. Among these, retail stores are expected to witness the highest CAGR during the forecast period. The retail stores are widely used for easy access to fertility and ovulation monitors. The high growth of this segment can be attributed to the inclination of patients toward self-monitoring of healthcare conditions.

Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=21037

For a better understanding of the market adoption of the home-use beauty industry, the market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness a significant CAGR during the forecast period on account of the growing various fertility and pregnancy test devices and medical treatments activities in countries like the U.S. and Canada. Furthermore, as reported by CDC, about 12% of women between the age group 15-44 years of age in the U.S. have difficulty in getting pregnant or carrying a pregnancy. The home care monitoring and diagnostics industry owing to the presence of well-established market players and frequent product launches in the region. Furthermore, many medical and aesthetic device companies are headquartered in the region, which are now focusing on diagnostic devices that can be easily used at home.

Some of the major players operating in the market include BioMerieux, Abbott, Church & Dwight, Quidel, Clinical Guard, Fairhaven Health, PRIMA Lab, Princeton BioMeditech, Wondfo, and Mankind Pharma.

Global female fertility and pregnancy rapid test Market Segmentation

Market Insight, by Device Types

• Digital Devices
• Line-indicator Devices

Market Insight, by Test Type

• FSH Urine Test
• LH Urine Test
• hCG Blood Test
• hCG Urine Test

Market Insight, by Product

• Fertility Rapid Test Kits
• Pregnancy Rapid Test Kits

Market Insight, by Distribution Channel

• By Distribution Channel
• Retail Stores
• Online Stores
• Gynecology and Fertility Clinics
• Other

Market Insight, by Region

• North America
  • U.S.
  • Canada
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • Rest of Asia-Pacific
• Rest of World

Top Company Profiles

• BioMerieux
  • Abbott
  • Church & Dwight
  • Quidel
  • Clinical Guard
  • Fairhaven Health
  • PRIMA Lab
  • Princeton BioMeditech
  • Wondfo
  • Mankind Pharma